Veterinary Molecular Diagnostics Market Likely to Reach $1.1 Billion by 2030

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Autoimmune Gastrointestinal Dysmotility Market During The Forecast Period 2026–2030?

The veterinary molecular diagnostics market has demonstrated strong growth over recent years. It is projected to expand from $0.7 billion in 2025 to $0.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This historical expansion is attributable to various factors, including the increasing prevalence of infectious and genetic animal diseases, advancements in molecular biology technology, the rising populations of companion and livestock animals, enhanced veterinary awareness and training, and the widespread adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $1.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the projected period include an increasing need for swift and precise molecular diagnostics, the uptake of ngs and high-throughput platforms, the broadening of veterinary genomics services, the incorporation of ai-driven diagnostic analysis, and an increasing focus on preventative veterinary care utilizing molecular testing. Key trends anticipated in the forecast period encompass the broadening use of pcr and rt-pcr-based diagnostics, the rising embrace of next-generation sequencing (ngs) in veterinary medicine, the creation of multiplex diagnostic kits for infectious diseases, the incorporation of molecular diagnostics into standard veterinary practices, and the development of automated and high-throughput molecular testing solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Which Major Factors Are Driving The Expansion Of The Autoimmune Gastrointestinal Dysmotility Market?

The widespread incidence of zoonotic diseases is projected to drive future growth in the veterinary molecular diagnostics market. Zoonotic diseases are infectious illnesses that can be transmitted between animals and humans. These conditions may be caused by bacteria, viruses, parasites, or fungi. Examples of common zoonoses include rabies, Lyme disease, salmonellosis, toxoplasmosis, and others. The prevalence of zoonotic diseases is influenced by factors such as deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics aid in the early detection of zoonotic diseases in animals, thereby preventing their spread to humans, and also improve disease management by enabling rapid, accurate identification of pathogens. For instance, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, in 2024, the number of reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to increase, reflecting a significant ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is a key driver for the veterinary molecular diagnostics market.

What Market Segments Are Evaluated Within The Autoimmune Gastrointestinal Dysmotility Market?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

What Industry Trends Are Redefining The Veterinary Molecular Diagnostics Market?

Major companies operating in the veterinary molecular diagnostics market are placing a strong emphasis on automation and scalability within diagnostic technologies, such as high-volume testing machines, to enhance diagnostic accuracy, improve testing efficiency, and enable quicker detection of diseases in animals. High-volume testing machines are advanced diagnostic instruments designed to efficiently process large quantities of samples, facilitating rapid and accurate analysis in laboratory or clinical settings, which is particularly beneficial for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, launched SmartChip, a cutting-edge molecular diagnostic testing device featuring quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp, and it considerably increases its testing capacity when integrated with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines.

Who Are The Top Market Participants Influencing The Autoimmune Gastrointestinal Dysmotility Market?

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

Read the full veterinary molecular diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

Which Region Currently Holds The Largest Share Of The Autoimmune Gastrointestinal Dysmotility Market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Gastrointestinal Dysmotility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20687&type=smp

Browse Through More Reports Similar to the Global Veterinary Molecular Diagnostics Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Parasiticides Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795